# Characterisation of the Immune Response to SARS-CoV-2 / COVID-19

> **NCT04729452** · — · COMPLETED · sponsor: **Cwm Taf University Health Board (NHS)** · enrollment: 160 (actual)

## Conditions studied

- Covid19

## Interventions

- **OTHER:** blood test

## Key facts

- **NCT ID:** NCT04729452
- **Lead sponsor:** Cwm Taf University Health Board (NHS)
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2024-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04729452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04729452, "Characterisation of the Immune Response to SARS-CoV-2 / COVID-19". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04729452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*